Clinical Trial Update: CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating checkpoint blockade therapy for relapsed mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma

Drugs mentioned

• Checkpoint blockade therapy

Snippet

Sponsor: University of Southampton | Conditions: Mesothelioma | Phase 3 | Status: COMPLETED